Risk factors for the development of obliterative bronchiolitis after lung transplantation - PubMed (original) (raw)
. 1996 Dec;15(12):1200-8.
I Tu, G J Berry, H Reichenspurner, V G Valentine, J V Conte, A Ting, I Johnstone, J Miller, R C Robbins, B A Reitz, J Theodore
Affiliations
- PMID: 8981205
Risk factors for the development of obliterative bronchiolitis after lung transplantation
R E Girgis et al. J Heart Lung Transplant. 1996 Dec.
Abstract
Background: Acute rejection has emerged as an important risk factor for obliterative bronchiolitis after lung transplantation. We performed a multivariate analysis to assess the impact of additional variables.
Methods: Seventy-four recipients (48 heart-lung, 18 single-lung, and 8 bilateral-lung recipients) who survived longer than 90 days and underwent transplantation more than 15 months before data analysis were included in this study. Several variables were entered into a Cox regression analysis to determine their association with the development of bronchiolitis obliterans syndrome.
Results: Bronchiolitis obliterans syndrome developed in 48 (65%) of 74 patients. Significant correlations were detected for acute rejection score, defined as the sum of pathologic grades of each separate acute rejection episode (p = 0.0004, likelihood ratio test value = 12.4) and for lymphocytic bronchiolitis (p = 0.03). In a bivariate model, episodes of organizing pneumonia and bacterial or fungal pneumonia significantly increased the likelihood ratio test value of the acute rejection score. The addition of the cytomegalovirus infection score, reflecting the frequency and severity of infection, to the combination of the acute rejection score and episodes of bacterial or fungal pneumonia resulted in a further significant increase in the likelihood ratio test value. Significant risk factors for moderate to severe stages of airflow limitation were at least one episode of acute rejection of grade > or = 2, younger recipient age, and any acute rejection episode 180 days or longer after transplantation.
Conclusions: Increasing frequency and severity of acute rejection episodes are strongly associated with the development of bronchiolitis obliterans syndrome. Lymphocytic bronchiolitis appeared to be significant by univariate analysis, but in a two-risk factor model, it did not augment the influence of acute rejection. Organizing pneumonia, bacterial or fungal pneumonia, and increasing severity and frequency of cytomegalovirus infections potentiate the effect of acute rejection. Late episodes of acute rejection and younger recipient age increase the risk for development of advanced disease.
Similar articles
- Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Heng D, et al. J Heart Lung Transplant. 1998 Dec;17(12):1255-63. J Heart Lung Transplant. 1998. PMID: 9883768 - Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG, Gupta MR, Walker JE Jr, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS. Valentine VG, et al. J Heart Lung Transplant. 2009 Feb;28(2):163-9. doi: 10.1016/j.healun.2008.11.907. J Heart Lung Transplant. 2009. PMID: 19201342 - Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA. Glanville AR, et al. Am J Respir Crit Care Med. 2008 May 1;177(9):1033-40. doi: 10.1164/rccm.200706-951OC. Epub 2008 Feb 8. Am J Respir Crit Care Med. 2008. PMID: 18263803 - Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease.
Epler GR. Epler GR. Clin Chest Med. 1988 Dec;9(4):551-6. Clin Chest Med. 1988. PMID: 3069287 Review. - Heart-lung transplantation: an overview.
Starnes VA. Starnes VA. Cardiol Clin. 1990 Feb;8(1):159-68. Cardiol Clin. 1990. PMID: 2407357 Review.
Cited by
- Novel approaches for long-term lung transplant survival.
Miller CL, O JM, Allan JS, Madsen JC. Miller CL, et al. Front Immunol. 2022 Jul 27;13:931251. doi: 10.3389/fimmu.2022.931251. eCollection 2022. Front Immunol. 2022. PMID: 35967365 Free PMC article. Review. - Esophageal Dysfunction in Post-lung Transplant: An Enigma.
Jadcherla AV, Litzenberg K, Balasubramanian G. Jadcherla AV, et al. Dysphagia. 2023 Jun;38(3):731-743. doi: 10.1007/s00455-022-10508-3. Epub 2022 Aug 12. Dysphagia. 2023. PMID: 35960395 Review. - Medical Complications of Lung Transplantation.
Park MS. Park MS. J Chest Surg. 2022 Aug 5;55(4):338-356. doi: 10.5090/jcs.22.066. J Chest Surg. 2022. PMID: 35924543 Free PMC article. - Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection.
Le Pavec J, Pradère P, Gigandon A, Dauriat G, Dureault A, Aguilar C, Henry B, Lanternier F, Savale L, Dolidon S, Gazengel P, Mussot S, Mercier O, Husain S, Lortholary O, Fadel E. Le Pavec J, et al. Transplant Direct. 2021 Feb 18;7(3):e675. doi: 10.1097/TXD.0000000000001128. eCollection 2021 Mar. Transplant Direct. 2021. PMID: 34113715 Free PMC article. - Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation.
Lin CM, Zamora MR. Lin CM, et al. Curr Transplant Rep. 2014;1(4):282-289. doi: 10.1007/s40472-014-0030-9. Epub 2014 Sep 12. Curr Transplant Rep. 2014. PMID: 32226712 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical